UPSC Prelims Practice Questions — Chintan Shivir in Ahmedabad focuses on scaling pharma exports as India crosses $30 billion mark

Question 1

The Chintan Shivir on 'Scaling up Pharma Exports' held in Ahmedabad in February 2026 was organised by the Department of Commerce primarily in collaboration with which one of the following bodies?

Accepted Answer

Pharmaceuticals Export Promotion Council of India (PHARMEXCIL)

Answer

Central Drugs Standard Control Organisation (CDSCO)

Answer

Directorate General of Foreign Trade (DGFT)

Answer

Indian Pharmacopoeia Commission (IPC)

Question 2

In the context of the 2026 Ahmedabad Chintan Shivir, the term 'iPHEX' refers to which one of the following?

Accepted Answer

The International Exhibition on Pharma and Healthcare Industry organised by PHARMEXCIL

Answer

An index measuring India's pharmaceutical import dependence

Answer

A production-linked incentive tier for high-value formulations

Answer

A digital registry of accredited clinical trial sites

Question 3

The figure of USD 30.47 billion widely cited in 2026 in connection with India's pharmaceutical sector represents which one of the following?

Accepted Answer

India's pharmaceutical exports in FY 2024-25

Answer

The size of India's domestic pharmaceutical market

Answer

India's projected pharmaceutical exports by 2030

Answer

The total outlay of the Biopharma SHAKTI initiative

Question 4

Which one of the following is the single largest destination for India's pharmaceutical exports, accounting for the highest share?

Accepted Answer

United States

Answer

United Kingdom

Answer

Germany

Answer

Japan

Question 5

The Biopharma SHAKTI initiative announced in the Union Budget 2026-27 was presented by the Union Minister heading which one of the following ministries?

Accepted Answer

Ministry of Science and Technology

Answer

Ministry of Chemicals and Fertilizers

Answer

Ministry of Commerce and Industry

Answer

Ministry of Health and Family Welfare

Question 6

Under the Production Linked Incentive (PLI) Scheme for Pharmaceuticals, applicants were classified into three groups (A, B and C) on the basis of which one of the following criteria?

Accepted Answer

The applicant's Global Manufacturing Revenue

Answer

The number of therapeutic areas the applicant covers

Answer

The applicant's volume of exports to regulated markets

Answer

The quantum of fresh investment committed by the applicant

Question 7

Under the Scheme for Promotion of Bulk Drug Parks, in-principle approval was granted to how many States for establishing Bulk Drug Parks?

Accepted Answer

Three

Answer

Two

Answer

Five

Answer

Seven

UPSC Prelims Practice Questions — Chintan Shivir in Ahmedabad focuses on scaling pharma exports as India crosses $30 billion mark

Q1. The Chintan Shivir on 'Scaling up Pharma Exports' held in Ahmedabad in February 2026 was organised by the Department of Commerce primarily in collaboration with which one of the following bodies?

Q2. In the context of the 2026 Ahmedabad Chintan Shivir, the term 'iPHEX' refers to which one of the following?

Q3. The figure of USD 30.47 billion widely cited in 2026 in connection with India's pharmaceutical sector represents which one of the following?

Q4. Which one of the following is the single largest destination for India's pharmaceutical exports, accounting for the highest share?

Q5. The Biopharma SHAKTI initiative announced in the Union Budget 2026-27 was presented by the Union Minister heading which one of the following ministries?

Q6. Under the Production Linked Incentive (PLI) Scheme for Pharmaceuticals, applicants were classified into three groups (A, B and C) on the basis of which one of the following criteria?

Q7. Under the Scheme for Promotion of Bulk Drug Parks, in-principle approval was granted to how many States for establishing Bulk Drug Parks?